
- 414 pages
- English
- PDF
- Available on iOS & Android
About this book
Kinase inhibition remains an area of significant interest, and growing importance, across academia and the pharmaceutical industry. There are now many marketed drugs that target kinases and a significant number of compounds are currently in various stages of clinical development. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years and builds on the first volume. This includes topics such as screening approaches to target kinases along with different modes of inhibition such as allosteric and covalent. Novel approaches such as macrocyclisation are considered along with how the properties of kinase inhibitors have evolved, including the potential for brain penetration. Recent areas of great importance also covered include cutting edge molecular modelling approaches and the importance of kinase mutations. The evolving biology of kinases has also resulted in increased interest in the immuno-oncology area and also pseudokinases as a target family. As with the first volume the book finishes with a forward looking view of how research against this fascinating target class may evolve.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Kinase Drug Discovery: Modern Approaches
- About the Editors
- Contents
- Chapter 1 - Introduction to Kinase Drug Discovery – Modern Approaches
- Chapter 2 - New Screening Approaches for Kinases
- Chapter 3 - The Screening and Design of Allosteric Kinase Inhibitors
- Chapter 4 - Covalent Inhibition of Kinases
- Chapter 5 - Small Molecule Macrocyclic Kinase Inhibitors
- Chapter 6 - The Design of Brain Penetrant Kinase Inhibitors
- Chapter 7 - Cutting Edge Approaches to Structure-based Computational Modelling of Kinases
- Chapter 8 - The Properties of Kinase Inhibitors
- Chapter 9 - Assessment and Optimisation of Kinase Inhibitor Selectivity to Achieve Candidates with an Appropriate Safety Profile
- Chapter 10 - Drugging the Kinome
- Chapter 11 - The Importance of Kinase Mutations in Cancer Drug Discovery
- Chapter 12 - Kinase Inhibition for Immuno-oncology
- Chapter 13 - A Structural Perspective of the Pseudokinome: Defining the Targetable Space
- Chapter 14 - The Future of Kinase Therapeutics
- Subject Index